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The loss of sonic hedgehog is an early change that occurs in the
mucosa prior to neoplastic transformation and correlates with the type
of intestinal metaplasia. Aberrant expression of CDX has also been
shown to correlate with the development of intestinal metaplasia.
Aim
To examine CDX2 expression in the non-cancerous mucosa of patients
with gastric cancer and compared it to CDX2 expression in controls
with intestinal metaplasia.
Methods
Sixty patients who had undergone endoscopic mucosal resection for
early gastric cancer and 60 gender- and age-matched controls were
studied. Two specimens each were obtained from the greater and lesser
curves of the corpus and from the greater curve of the antrum. Expres-
sion of CDX2 and sonic hedgehog were evaluated by immunostaining.
Results
Gastric cancer was associated with a higher frequency of incomplete
intestinal metaplasia (OR ¼ 8.3; 95%CI, 3.7–18.9, P < 0.001). CDX2
negatively correlated with sonic hedgehog expression, however, multi-
variate analysis revealed that CDX2 correlated with the intestinal meta-
plasia scores. Sonic hedgehog indices were lower and CDX2 staining in
the corpus lesser curve was higher in the cancer group than in the con-
trols. Sonic hedgehog indices in the corpus decreased and CDX2 indices
in both areas increased in patients in the ascending order of those
without intestinal metaplasia, those with complete intestinal metaplasia
and those with incomplete intestinal metaplasia (P < 0.001).
Conclusions
Loss of sonic hedgehog expression and aberrant expression of CDX2
correlates with the type of intestinal metaplasia and may play a role in
carcinogenesis.
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INTRODUCTION
The most widely accepted notion about gastric cancer
is that the majority of cases evolve through a multi-
step process starting with superficial gastritis, pro-
gressing to atrophy with intestinal metaplasia (IM),
followed by the development of dysplasia and finally
carcinoma.1
Gastric IM has been classified as complete (small
intestine) or incomplete (colonic) using immunohisto-
chemical staining techniques. Another classification
categorizes IM into three types: I (complete), and II and
III (incomplete).2 Type I (complete) involves sialomuc-
ins similar to those found in the mucosa of the small
intestine and is the most common type. The columnar
cells of type III contain sulphomucins. A large number
of studies have evaluated the significance of type III
IM as a risk factor for intestinal-type gastric cancer
using surgical specimens of human stomach with gas-
tric cancer.3–6 However, type III IM in biopsy samples
is highly specific for cancer but has low sensitivity.2
Moreover, the detection of IM in routinely obtained
endoscopic biopsy material is subject to sampling error
and is not thought to be a suitable marker to detect
groups at high risk for gastric cancer.7 We have previ-
ously shown that IM, especially incomplete IM, detec-
ted in endoscopic biopsy samples from the corpus
lesser curve is highly specific and sensitive for gastric
cancer and is therefore likely to be a histological high-
risk marker for the intestinal-type gastric cancer. How-
ever, the development of IM, as well as its relationship
to gastric cancer, remains unclear.
The peptide morphogen called hedgehog was ini-
tially identified during genetic screening of the fruit
fly Drosophila.8 Mammalian members of the hedgehog
morphogenic family such as sonic hedgehog (Shh),
Indian hedgehog (Ihh) and desert hedgehog (Dhh) are
essential regulators of many patterning processes
throughout both vertebrate and invertebrate develop-
ment.9 Shh and Ihh are co-expressed in the gut endo-
derm in partially overlapping patterns beginning in
the early somite stages.10, 11 Shh null mice exhibit
gastrointestinal malformations such as incomplete
separation of the trachea and oesophagus, gut malro-
tation, small intestinal and anal atresias, and replace-
ment of the normal gastric epithelium with intestinal
metaplastic cells.12, 13 In a study conducted on humans
by van den Brink et al. Shh mRNA and Shh protein
were shown to be abundantly expressed in the normal
gastric fundus, whereas no Shh protein was observed
in the oesophagus or intestine. Ectopic Shh expression
was observed in fundic gland metaplasia.14, 15 We
have recently shown that the loss of Shh is an early
change that occurs in the mucosa prior to neoplastic
transformation and correlates with the type of IM.16
The CDX proteins are intestine-specific transcription
factors encoded by human cdx1 and cdx2 genes.17
These genes constitute the mammalian homologues of
the Drosophilia homeobox gene, caudal, which is
required for anterior–posterior regional identity.18, 19
In adult mammals, the expression of these genes is
restricted to the epithelium of the gut from the duo-
denum to the large intestine, where they act as master
regulators for intestinal development and differenti-
ation.17 In particular, loss of CDX2 expression leads to
focal gastric differentiation in the colon,20 while aber-
rant expression of CDX2 in the upper gastrointestinal
tract is a key event in the pathogenesis of Barrett’s
mucosa in the oesophagus and of IM in the stom-
ach.21, 22 CDX2 is also expressed in adenocarcinomas
from various organs such as the stomach, colon,
pancreas, gall bladder and lung, and may be clinically
useful in better predicting outcome in patients with
advanced cancer.23– 27
Loss of Shh and aberrant expression of CDX2 corre-
late with the development of IM. This suggests that
the ability to predict neoplastic transformation may be
enhanced when both Shh and CDX2 expression are
taken into consideration. A study of both CDX2 and
Shh expression in the background mucosa of patients
with gastric cancer might help to clarify our under-
standing of how IM develops and its relationship to
gastric cancer, but no such study has been performed.
Here, therefore, we compared Shh and CDX2 expres-
sion in control subjects with expression in the
non-cancerous mucosa of patients with early intesti-
nal-type gastric cancer using fixed-point biopsy sam-
ples. We also assessed the relationship between the
expression of these two proteins and the scores for
gastritis related to Helicobacter pylori infection.
METHODS
This was a case–control study of patients with a his-
tory of endoscopic mucosal resection (EMR) for early
gastric cancer. The study was performed at the Osaka
Medical Center for Cancer and Cardiovascular Diseases
and Aishinkai Nakae Hospital in Japan. Patients were
enrolled for the study between November 2003 and
January 2005.
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Patients
Patients with a medical history of EMR for early
stage, non-cardia intestinal-type gastric cancer with-
out lymph node metastasis were evaluated on the
basis of age, gender and the presence of H. pylori
infection. Subjects who underwent endoscopy for fol-
low-up to peptic ulcer or health screening formed the
non-cancer control group. Patients were excluded if
they had undergone H. pylori eradication, used anti-
secretory or non-steroidal anti-inflammatory drugs,
or had haemorrhagic diseases, insulin-dependent dia-
betes mellitus cirrhosis or renal failure. Demographic
data collected at study entry included age, gender,
smoking habit, alcohol consumption and drug treat-
ments. Drinking and smoking were defined as ‘regu-
lar’ when consumption was more than 35 g for
ethanol or five cigarettes per day respectively. The
study was approved by the Osaka Medical Center for
Cancer and Cardiovascular Diseases Ethical Commit-
tee, and written informed consent was obtained from
each patient.
Histopathological grading
Endoscopies were performed by experienced endosco-
pists after patients had fasted for 12 h. Two speci-
mens from each sample site, the greater curve of the
antrum and greater and lesser curves of the corpus,
were stained with haematoxylin and eosin, then addi-
tionally with Giemsa stain to score H. pylori density.
A Visual Analogue Scale ranging from 0 (absent/nor-
mal) to 3 (maximal intensity) was used to score the
following four parameters: inflammation (inflamma-
tory cell infiltration), glandular atrophy, IM and H.
pylori density according to the updated Sydney clas-
sification.28 Well-oriented tissue sections with gastric
pits and glands cut longitudinally and visible along
the entire isthmus zone were selected for quantitative
analysis.
Subtyping IM
Samples were also stained with Alcian blue (AB)/high
iron diamine (HID) to categorize IM as the complete
type (type I) or incomplete type (types II and III).
Slides were immersed in HID solution for 20 h at room
temperature, then rinsed with deionized water and
stained with 1% AB (pH 2.5) for 2 min. IM subtyping
was done according to the system of Filipe et al.2
Diagnosis of H. pylori
Venous blood samples were analysed for specific IgG
H. pylori antibodies with an enzyme-linked immuno-
sorbent assay (ELISA) kit using the E plate test (Eiken
Kagaku, Inc., Tokyo, Japan). Patients were considered to
be infected with H. pylori if the serum test was positive
or if evidence of chronic gastritis/atrophy with H. pylori
was evident upon histopathological examination.
Immunohistochemistry
Three adjacent sections 4-lm thick were cut onto each
of three polylysine-coated glass slides. The sections
were deparaffinized, washed in phosphate-buffered
saline (PBS), then microwaved in sodium citrate buffer
for antigenic retrieval. Immunohistochemical staining
for Shh and CDX2 was performed using the Vectastain
ABC-AP kit (Vector Laboratories, Burlingame, CA,
USA). Endogenous peroxidase activity was quenched
by incubation in 3% hydrogen peroxide in methanol
for 30 min. After non-specific binding was blocked,
sections were incubated with goat polyclonal alpha-
Shh antibody (1:100; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) or CDX2 (1:500; BioGenex, San
Ramon, CA, USA) overnight at 4 C. After washing in
PBS, the sections were incubated for 30 min with biot-
inylated IgG (DAKO, Carpinteria, CA, USA). They were
then washed and incubated with an avidin and biotin-
ylated alkaline phosphatases complex for 30 min,
washed in PBS, stained in 0.05% diaminobenzidine
hydrochloride solution for 5 min, then counterstained
with haematoxylin. After dehydration with xylene, the
sections were mounted.
Shh or CDX2 staining was quantified for each subject
as the number of stained cells per gland or per 100 cells.
Statistical analyses
Values are expressed as the mean  s.d. or the median
with a 25–75% range, whichever was appropriate
depending on whether the data were normally distri-
buted. Mantel–Haenszel chi-square analysis and the
unpaired t-test were performed to measure differences
in demographic and clinical characteristics. Statistical
analyses for significant differences of parameters were
performed using the non-parametric Mann–Whitney
U-test between two groups. Among three groups, the
Kruskal–Wallis test was used and all pairwise multiple
comparisons were performed using the Dunnet method.
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The Pearson chi-square analysis was used to detect a
significant difference in the type of IM between the two
groups and the Mantel–Haenszel chi-square analysis
was used to assess the relationship between gastric can-
cer and incomplete IM by odds ratio (OR) and 95% con-
fidence interval (CI). Spearman’s correlation coefficient
was calculated to examine correlations among histolog-
ical parameters. Stepwise linear regression analysis was
performed between Shh or CDX2 expression and other
histological scores. A two-sided P-value of less than
0.05 was considered statistically significant. All statisti-
cal computations were performed using SPSS (SPSS
Inc., Chicago, IL, USA).
RESULTS
The study groups consisted of 60 patients with EMR for
early gastric cancer (cancer group) and an additional 60
in the control group who were matched to the EMR
group by gender, age and the presence of H. pylori
infection. Demographic and clinical characteristics of
the study groups are shown in Table 1. Malignant
lesions in the corpus were found in 24 patients and 28
patients had lesions in the lower stomach. In the
remaining eight patients, malignant lesions were
located in two different locations. Atrophy and IM
scores for each part and inflammation in the greater
curve of the corpus were significantly higher in the can-
cer group than in the control group (Figure 1).
Incomplete IM was present in 46 patients (76.7%) in
the cancer group and 17 patients (28.3%) in the con-
trol group. Relatively more patients in the gastric can-
cer group had incomplete IM, with high significance
(P < 0.001) (Table 2). The sensitivity and specificity of
incomplete IM for gastric cancer were 76.7% and
71.7%, respectively, and gastric cancer was associated
with a higher frequency of incomplete IM (OR ¼ 8.3;
95% CI, 3.7–18.9, P < 0.001).
A large number of Shh-positive cells in the fundic
glands (Figure 2a) and a few CDX2-positive cells in
areas with IM (Figure 2b) were seen in controls with-
out atrophy. Shh-positive cells were dramatically
reduced (Figure 2c) and many CDX2-positive cells
were seen (Figure 2d) in cancer patients with complete
IM. In specimens that contained incomplete IM, Shh
expression was nearly absent (Figure 2e) and a large
number of CDX2-positive cells were seen (Figure 2f) in
the whole specimens, especially in cancer patients. The
presence of Shh peptide and CDX2 significantly corre-
lated with the scores of inflammation from the greater
curve of the corpus and the scores of atrophy and IM
in each part (Table 3). CDX2 expression negatively
correlated with Shh expression (r ¼ )0.73, P < 0.001,
Figure 3). In multivariate analysis, Shh expression in
the corpus correlated significantly only with the atro-
phy scores (P < 0.001). CDX2 correlated significantly
with the IM scores (P < 0.001) and also with the Shh
scores in the lesser curve of the corpus (P ¼ 0.03).
The median of Shh indices in the corpus was signifi-
cantly lower (18 vs. 34, P < 0.001 in the greater curve
of the corpus; 0.4 vs. 9.2, P ¼ 0.002 in the lesser
curve of the corpus) and the median percentage of
CDX2-positive cells in the lesser curve of the corpus
was significantly higher (80 vs. 10, P < 0.001) in the
cancer group than in the control group (Figure 4). The
Shh indices in the corpus decreased and the CDX2
indices in the respective areas increased in patients
without IM, patients with complete IM and patients
with incomplete IM, in that order (P < 0.001). There
was a significant difference between the complete and
incomplete IM groups for Shh expression in the corpus
and for CDX2 expression in both the antrum and the
lesser curve of the corpus (Figure 5).
DISCUSSION
We previously reported that Shh expression correlated
with atrophy and IM score, and that its expression
decreased in H. pylori-negative controls, -positive con-
trols and the cancer group, in that order.16 In the pre-
sent study, CDX2 positively correlated with atrophy
and IM scores, but negatively correlated with Shh
expression. CDX2 expression in the lesser curve of the
corpus was significantly higher in the cancer group
than in the control group. However, we found no sig-
nificant difference between Shh and CDX2 expression




(n ¼ 60) P-values
Age mean (s.d.) 69 (10) 69 (8) 0.72a
Gender male/female 46/14 46/14
Helicobacter pylori-positive 90% 90%
Current smokers 28.3% 38.3% 0.47b
Regular alcohol intake 46.7% 41.7% 0.80b
P-values calculated using: a unpaired t-test, b Mantel–Haens-
zel chi-square analysis.
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that corresponded to the location of the malignant
lesions. Thus, the loss or reduction of Shh expression
and aberrant CDX2 expression seem to be essential
factors in the induction of carcinogenesis during the
early phases of transformation, which suggests in turn
that numerous other genetic changes such as p53,
k-ras and microsatellite instability, etc. may also be
involved. Recently, Mutoh et al. reported that gastric
polyps developing from the intestinal metaplastic
mucosa of all stomachs in Cdx2-transgenic mice con-
sisted of intestinal-type adenocarcinoma containing
p53 and APC gene mutations,29 and suggested that
aberrant CDX2 expression inducing IM plays a signifi-
cant role in the genesis and progression of gastric car-
cinoma. However, there is no direct evidence of loss of
Shh expression for carcinogenesis. Ramalho-Santos
et al. reported that Shh-null mice exhibit an over-
growth of stomach epithelium that, upon histological
examination, appears to be glandular epithelium remi-
niscent of an intestinal phenotype. Moreover, the
transformation of the stomach epithelium does not
depend on alterations in the expression of the Cdx2
genes.12 Thus, independently of CDX2, Shh seems to
be associated with gastric cancer preventing atrophy
prior to IM.
The IM phenotype is characterized by the presence of
intestinal differentiation markers like apomucin
MUC2.30 It has been reported that Shh-expressing cells
are present adjacent to metaplastic glands containing
goblet cells expressing MUC2, and that the expression
of Shh and MUC2 is mutually exclusive.15 Tsukamoto
et al. analysed CDX2 mRNA levels in isolated gastric
glands and demonstrated that the expression of CDX2
as well as of MUC2 is progressively upregulated with
intestinalization from the gastric type to the gastric/
intestinal-mixed type to the intestinal type.31 Thus, Shh
appears to be an essential signal of fundic gland differ-
entiation and might prevent the modulation of the dif-
ferentiated gastric mucosa to an IM phenotype. In
contrast, CDX2 seems to be a signal essential for modu-
lation to an IM phenotype and might function by pre-
venting the execution of a fundic gland differentiation
pattern. Atrophic change, specifically the loss of parietal
cells, leads to the loss of Shh expression, which might in
turn lead to aberrant expression of CDX2.
Shh binds to its receptor Patched (Ptc), which redu-
ces the inhibitory effect of Ptc on another transmem-
brane protein, Smoothened (Smo). Shh signalling is
finally carried out by members of the Gli-family of
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Figure 1. Comparisons of histological scores between the control group (N) and the cancer group (C). Mean scores with
95% confidence intervals. P-values were calculated using the non-parametric Mann–Whitney U-test.
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Figure 2. Expression of sonic hedgehog (Shh) and CDX2 in biopsy tissue from the lesser curve of the corpus from cancer
and control groups. In specimens from control subjects without atrophy, Shh staining observed in parietal cells (a) and
CDX2-positive cells were observed only in areas with intestinal metaplasia (IM) (b). Reduced numbers of Shh-stained cells
(c) and many CDX2-positive cells were seen in the cancer patients (d). In specimens that contained incomplete IM, Shh
expression was essentially absent (e) and a large number of CDX2-positive cells were detected (f).
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transcription factors, which co-ordinately pattern the
dorsal–ventral axis of the spinal cord.32–34 Runx3, a
runt domain transcription factor, is a major growth
regulator of gastric epithelial cells and some gastric
epithelial cells in the Runx3)/) mouse differentiate
into intestinal-type cells expressing CDX2.35 Sucrase-
isomaltase, glucagon, carbonic anhydrase I, lactase,
MUC2, etc. have been suggested as candidates for
CDX2-regulated target genes. Moreover, CDX2 appears
to directly regulate the LI-cadherin (cadherin 17) gene,
which is an intestine-specific cell adhesion molecule,
and hephaestin, which plays a critical role in the
transport of iron into the intestinal epithelium.36 In
this way, CDX2 and Shh seem to be involved in intes-
tinal transformation interdependently through different
signal cascades.
Table 3. Correlation among
the histological parameters Inflammation Atrophy
Intestinal
metaplasia Shh
Shh in the antrum )0.17 )0.46*** )0.24*
Shh in the corpus: greater curve )0.43*** )0.79*** )0.54***
Shh in the corpus: lesser curve )0.24* )0.73*** )0.70***
CDX2 in the antrum )0.15 0.55*** 0.75*** )0.39***
CDX2 in the corpus: greater curve 0.29** 0.56*** 0.66*** )0.52***
CDX2 in the corpus: lesser curve 0.05 0.67*** 0.83*** )0.73***


































































Figure 4. Comparison of sonic hedgehog (Shh) (a) and
CDX2 (b) expression in control and cancer groups. Hori-
zontal bar, median; box, 25th–75th interquartile range;
vertical lines, range of values. P-values were calculated
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Figure 3. Correlation between the sonic hedgehog (Shh)
and CDX2 staining indices in the lesser curve of the cor-
pus in controls (s) and patients with gastric cancer (d).
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Gastric juice pH is likely a useful marker of high-
risk gastric cancer.37, 38 Dimmler et al. reported that
transcription of Shh in a gastric cancer cell line was
significantly increased in culture conditions with low
pH and suggested that an increase in gastric pH may
play a role in the development of gastric mucosa atro-
phy via reduction of Shh transcription.39 In contrast,
in the intestinal cell line Caco2, CDX2 expression is
downregulated under acidic conditions.40 CDX2
expression in intestinal cells is lost in duodenal gastric
metaplasia, which is closely associated with gastric
hypersecretion and increased acid load in the duode-
num.40 The acid-induced loss of CDX2 expression may
be a reflection of the pathological mechanism of IM in
the stomach. Thus, gastric CDX2 expression and intes-
tinal trans-differentiation in the gastric mucosa can be
suppressed by the normal acidic milieu of the corpus
mucosa. Hypoacidity due to reduced acid secretion
caused by gastric atrophy might allow the upregula-
tion of CDX2, resulting in IM.
The results of this study show that a small number
of CDX2-positive cells occur in the antrum even with-
out the presence of IM, although no expression was
seen in the corpus without IM. In previous reports,
CDX2 expression in antrum infected with H. pylori
without obvious IM has been described and a small
amount of CDX2 expression in isolated gastric-type
gland from the antrum has also been shown.31, 41 A
small amount of antrum CDX2 expression without IM
that is unrelated to changes in Shh expression might
trigger the initiation and development of IM.
In addition, we found a significant difference in
CDX2 and Shh expression according to the type of IM
involved. It has been reported that the majority of
intestinal-type goblet cells in Foxa 3/Cdx2 transgenic
mice produced sulphated mucin, which indicates type
III IM, although intestinal genes such as alkaline phos-
phatase, villin, Muc2 and trefoil family factor 3 were
also activated.22 However, the molecular pathogenesis
underlying the morphological alterations caused by
complete and incomplete IM, and type III IM remain
largely unknown. It is also unclear whether CDX2 and
Shh are specifically involved with these intestinal
transformations.
In conclusion, our study suggests that the loss of
Shh and aberrant expression of CDX2 in H. pylori-
associated atrophic gastritis are early changes that
occur in the mucosa prior to cellular transformation
and correlate with the type of IM. Shh and CDX2
may play an important and interdependent role in
sustaining gastric epithelial differentiation and might
be subsequently involved in carcinogenesis at an
early stage.
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Figure 5. Comparison of sonic hedgehog (Shh) (a) and
CDX2 (b) expression in patients without intestinal metapl-
asia (IM), complete IM and incomplete IM. Horizontal bar,
median; box, 25th–75th interquartile range; vertical lines,
range of values. P-values were calculated using the Dun-
net method.
78 A. SHIOTANI et al.
ª 2006 The Authors, Aliment Pharmacol Ther 24 (Suppl. 4), 71–80
Journal compilation ª 2006 Blackwell Publishing Ltd
REFERENCES
1. Correa P. Chronic gastritis as a cancer
precursor. Scand J Gastroenterol Suppl
1984; 104: 131–6.
2. Filipe MI, Potet F, Bogomoletz WV,
et al. Incomplete sulphomucin-secreting
intestinal metaplasia for gastric cancer.
Preliminary data from a prospective
study from three centres. Gut 1985; 26:
1319–26.
3. El-Zimaity HM, Ota H, Graham DY,
Akamatsu T, Katsuyama T. Patterns of
gastric atrophy in intestinal type gastric
carcinoma. Cancer 2002; 94: 1428–36.
4. Matsuzaki H, Shimada S, Uno K, Tsuruta
J, Ogawa M. Novel subtyping of intesti-
nal metaplasia in the human stomach:
brain-type glycogen phosphorylase
expression in the proliferative zone and
its relationship with carcinogenesis. Am
J Clin Pathol 1998; 109: 181–9.
5. Matsukura N, Suzuki K, Kawachi T,
et al. Distribution of marker enzymes
and mucin in intestinal metaplasia in
human stomach and relation to com-
plete and incomplete types of intestinal
metaplasia to minute gastric carcino-
mas. J Natl Cancer Inst 1980; 65: 231–
40.
6. Iida F, Kusama J. Gastric carcinoma and
intestinal metaplasia. Significance of
types of intestinal metaplasia upon
development of gastric carcinoma. Can-
cer 1982; 50: 2854–8.
7. Meining A, Morgner A, Miehlke S, Bay-
erdorffer E, Stolte M. Atrophy–metapla-
sia–dysplasia–carcinoma sequence in
the stomach: a reality or merely an
hypothesis? Best Pract Res Clin Gast-
roenterol 2001; 15: 983–98.
8. Nusslein-Volhard C, Wieschaus E. Muta-
tions affecting segment number and
polarity in Drosophila. Nature 1980;
287: 795–801.
9. Hammerschmidt M, Brook A, McMahon
AP. The world according to hedgehog.
Trends Genet 1997; 13: 14–21.
10. Bitgood MJ, McMahon AP. Hedgehog
and Bmp genes are coexpressed at many
diverse sites of cell-cell interaction in
the mouse embryo. Dev Biol 1995; 172:
126–38.
11. Echelard Y, Epstein DJ, St-Jacques B,
et al. Sonic hedgehog, a member of a
family of putative signaling molecules,
is implicated in the regulation of CNS
polarity. Cell 1993; 75: 1417–30.
12. Ramalho-Santos M, Melton DA, McMa-
hon AP. Hedgehog signals regulate mul-
tiple aspects of gastrointestinal
development. Development 2000; 127:
2763–72.
13. Litingtung Y, Lei L, Westphal H, Chiang
C. Sonic hedgehog is essential to fore-
gut development. Nat Genet 1998; 20:
58–61.
14. van den Brink GR, Hardwick JC, Tytgat
GN, et al. Sonic hedgehog regulates
gastric gland morphogenesis in man
and mouse. Gastroenterology 2001; 121:
317–28.
15. van den Brink GR, Hardwick JC, Nielsen
C, et al. Sonic hedgehog expression cor-
relates with fundic gland differentiation
in the adult gastrointestinal tract. Gut
2002; 51: 628–33.
16. Shiotani A, Iishi H, Uedo N, et al. Evi-
dence that loss of sonic hedgehog is an
indicator of Helicobacter pylori-induced
atrophic gastritis progressing to gastric
cancer. Am J Gastroenterol 2005; 100:
581–7.
17. Silberg DG, Swain GP, Suh ER, Traber
PG. Cdx1 and cdx2 expression during
intestinal development. Gastroenterology
2000; 119: 961–71.
18. Macdonald PM, Struhl G. A molecular
gradient in early Drosophila embryos
and its role in specifying the body pat-
tern. Nature 1986; 324: 537–45.
19. Moreno E, Morata G. Caudal is the Hox
gene that specifies the most posterior
Drosophile segment. Nature 1999; 400:
873–7.
20. Beck F, Chawengsaksophak K, Waring
P, Playford RJ, Furness JB. Reprogram-
ming of intestinal differentiation and
intercalary regeneration in Cdx2 mutant
mice. Proc Natl Acad Sci U S A 1999;
96: 7318–23.
21. Phillips RW, Frierson HF Jr, Moskaluk
CA. Cdx2 as a marker of epithelial
intestinal differentiation in the esopha-
gus. Am J Surg Pathol 2003; 27: 1442–
7.
22. Silberg DG, Sullivan J, Kang E, et al.
Cdx2 ectopic expression induces gastric
intestinal metaplasia in transgenic mice.
Gastroenterology 2002; 122: 689–96.
23. Matsumoto K, Mizoshita T, Tsukamoto
T, et al. Cdx2 expression in pancreatic
tumors: Relationship with prognosis of
invasive ductal carcinomas. Oncol Rep
2004; 12: 1239–43.
24. Piscitelli D, Ingravallo G, Resta L, Fiore
MG, Maiorano E. Oncocytic adenocarci-
noma of the rectum with diffuse intra-
luminal microcalcifications: the first
reported case. Virchows Arch 2003;
443: 579–82.
25. Kaimaktchiev V, Terracciano L, Tornillo
L, et al. The homeobox intestinal differ-
entiation factor CDX2 is selectively
expressed in gastrointestinal adenocarci-
nomas. Mod Pathol 2004; 17: 1392–9.
26. Mizoshita T, Tsukamoto T, Nakanishi H,
et al. Expression of Cdx2 and the phe-
notype of advanced gastric cancers:
relationship with prognosis. J Cancer
Res Clin Oncol 2003; 129: 727–34.
27. Seno H, Oshima M, Taniguchi MA, et al.
CDX2 expression in the stomach with
intestinal metaplasia and intestinal-type
cancer: prognostic implications. Int J
Oncol 2002; 21: 769–74.
28. Dixon MF, Genta RM, Yardley JH, Cor-
rea P. Classification and grading of gas-
tritis. The updated Sydney System.
International Workshop on the Histopa-
thology of Gastritis, Houston 1994. Am
J Surg Pathol 1996; 20: 1161–81.
29. Mutoh H, Sakurai S, Satoh K, et al.
Development of gastric carcinoma from
intestinal metaplasia in Cdx2-transgenic
mice. Cancer Res 2004; 64: 7740–7.
30. Seregni E, Botti C, Massaron S, et al.
Structure, function and gene expression
of epithelial mucins. Tumori 1997; 83:
625–32.
31. Tsukamoto T, Inada K, Tanaka H, et al.
Down-regulation of a gastric transcrip-
tion factor, Sox2, and ectopic expres-
sion of intestinal homeobox genes,
Cdx1 and Cdx2: inverse correlation dur-
ing progression from gastric/intestinal-
mixed to complete intestinal metaplasia.
J Cancer Res Clin Oncol 2004; 130:
135–45.
32. Oldak M, Grzela T, Lazarczyk M, Male-
jczyk J, Skopinski P. Clinical aspects of
disrupted Hedgehog signaling (review).
Int J Mol Med 2001; 8: 445–52.
33. Faller G, Kirchner T. Immunological and
morphogenic basis of gastric mucosa
atrophy and metaplasia. Virchows Arch
2005; 446: 1–9.
34. Jacob J, Briscoe J. Gli proteins and the
control of spinal-cord patterning. EMBO
Rep 2003; 4: 761–5.
35. Fukamachi H, Ito K, Ito Y. Runx3-/-
gastric epithelial cells differentiate into
SONIC HEDGEHOG AND CDX2 EXPRESSION IN INTEST INAL METAPLASIA 79
ª 2006 The Authors, Aliment Pharmacol Ther 24 (Suppl. 4), 71–80
Journal compilation ª 2006 Blackwell Publishing Ltd
intestinal type cells. Biochem Biophys
Res Commun 2004; 321: 58–64.
36. Hinoi T, Lucas PC, Kuick R, Hanash S,
Cho KR, Fearon ER. CDX2 regulates
liver intestine-cadherin expression in
normal and malignant colon epithelium
and intestinal metaplasia. Gastroenterol-
ogy 2002; 123: 1565–77.
37. Shiotani A, Iishi H, Kumamoto M,
Nakae Y. Helicobacter pylori infection
and increased nitrite synthesis in the
stomach. Inflammation and atrophy
connections. Dig Liver Dis 2004; 36:
327–32.
38. Shiotani A, Iishi H, Uedo N, et al. Hypo-
acidity combined with high gastric juice
nitrite induced by Helicobacter pylori
infection is associated with gastric can-
cer. Aliment Pharmacol Ther 2004; 20
(Suppl 1): 48–53.
39. Dimmler A, Brabletz T, Hlubek F, et al.
Transcription of sonic hedgehog, a
potential factor for gastric morphogen-
esis and gastric mucosa maintenance, is
up-regulated in acidic conditions. Lab
Invest 2003; 83: 1829–37.
40. Faller G, Dimmler A, Rau T, et al. Evi-
dence for acid-induced loss of Cdx2
expression in duodenal gastric metapla-
sia. J Pathol 2004; 203: 904–8.
41. Satoh K, Mutoh H, Eda A, et al. Aber-
rant expression of CDX2 in the gastric
mucosa with and without intestinal me-
taplasia: effect of eradication of Heli-
cobacter pylori. Helicobacter 2002; 7:
192–8.
80 A. SHIOTANI et al.
ª 2006 The Authors, Aliment Pharmacol Ther 24 (Suppl. 4), 71–80
Journal compilation ª 2006 Blackwell Publishing Ltd
